PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
1-Year Return
33.7%
This Quarter Return
+19.19%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$783M
AUM Growth
+$49.2M
(+6.7%)
Cap. Flow
-$26.8M
Cap. Flow
% of AUM
-3.42%
Top 10 Holdings %
Top 10 Hldgs %
34.67%
Holding
106
New
16
Increased
38
Reduced
39
Closed
12
Top Buys
| 1 |
Teleflex
TFX
|
$23.8M |
| 2 |
Keros Therapeutics
KROS
|
$13M |
| 3 |
Stryker
SYK
|
$10.1M |
| 4 |
Viridian Therapeutics
VRDN
|
$9.67M |
| 5 |
Arcus Biosciences
RCUS
|
$9.33M |
Top Sells
| 1 |
United Therapeutics
UTHR
|
$17M |
| 2 |
Elevance Health
ELV
|
$15M |
| 3 |
Humana
HUM
|
$11.2M |
| 4 |
Tenet Healthcare
THC
|
$9.17M |
| 5 |
Boston Scientific
BSX
|
$8.75M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Oscar Health
OSCR
$4.75B
| $5.3M | 0.68% |
+250,000
| New | +$5.3M |
|
52
MoonLake Immunotherapeutics
MLTX
$3.79B
| $5.18M | 0.66% |
102,813
+1,589
| +2% | +$80.1K |
|
53
Teva Pharmaceuticals
TEVA
$21.2B
| $5.14M | 0.66% |
285,294
-68,648
| -19% | -$1.24M |
|
54
DexCom
DXCM
$31.7B
| $4.73M | 0.6% |
70,588
-86,267
| -55% | -$5.78M |
|
55
AnaptysBio
ANAB
$590M
| $4.63M | 0.59% |
138,100
-118,207
| -46% | -$3.96M |
|
56
Terns Pharmaceuticals
TERN
$618M
| $4.55M | 0.58% |
545,751
+155,481
| +40% | +$1.3M |
|
57
UroGen Pharma
URGN
$870M
| $4.41M | 0.56% |
347,541
+73,076
| +27% | +$928K |
|
58
Veracyte
VCYT
$2.48B
| $4.4M | 0.56% |
129,260
-80,215
| -38% | -$2.73M |
|
59
Crinetics Pharmaceuticals
CRNX
$3.23B
| $3.97M | 0.51% |
77,623
-63,752
| -45% | -$3.26M |
|
60
BioCryst Pharmaceuticals
BCRX
$1.74B
| $3.53M | 0.45% |
464,048
+63,600
| +16% | +$483K |
|
61
QuidelOrtho
QDEL
$1.89B
| $3.42M | 0.44% |
+75,000
| New | +$3.42M |
|
|
AVDL
62
Avadel Pharmaceuticals
AVDL
$1.46B
| $3.34M | 0.43% |
254,827
-123,462
| -33% | -$1.62M |
|
|
LENZ
63
LENZ Therapeutics
LENZ
$1.14B
| $3.31M | 0.42% |
+139,357
| New | +$3.31M |
|
|
THRD
64
DELISTED
Third Harmonic Bio
THRD
| $3.22M | 0.41% |
237,820
+104,495
| +78% | +$1.42M |
|
65
Lifestance Health
LFST
$2.13B
| $3.15M | 0.4% |
+450,000
| New | +$3.15M |
|
66
TG Therapeutics
TGTX
$5.06B
| $2.96M | 0.38% |
126,471
-53,849
| -30% | -$1.26M |
|
67
SI-BONE Inc
SIBN
$705M
| $2.59M | 0.33% |
185,316
+32,301
| +21% | +$452K |
|
68
Insmed
INSM
$30.1B
| $2.59M | 0.33% |
35,433
-44,838
| -56% | -$3.27M |
|
69
Dynavax Technologies
DVAX
$1.17B
| $2.44M | 0.31% |
219,451
+2,629
| +1% | +$29.3K |
|
70
Nuvalent
NUVL
$5.74B
| $2.39M | 0.31% |
23,400
-19,488
| -45% | -$1.99M |
|
71
Arvinas
ARVN
$559M
| $2.37M | 0.3% |
96,183
-28,978
| -23% | -$714K |
|
72
Merus
MRUS
$5.01B
| $2.27M | 0.29% |
45,349
+197
| +0.4% | +$9.84K |
|
73
Alphatec Holdings
ATEC
$2.45B
| $2.2M | 0.28% |
396,336
-456,080
| -54% | -$2.54M |
|
74
ESSA Pharma
EPIX
$11M
| $2.1M | 0.27% |
345,902
+93,830
| +37% | +$569K |
|
75
Annexon
ANNX
$236M
| $1.95M | 0.25% |
328,613
+1,768
| +0.5% | +$10.5K |
|